Peptidream (4587) Stock Forecast & Price Target

Compare

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

4587 Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Peptidream

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

4587 Stock 12 Month Forecast

Average Price Target

¥3,230.00

▲(93.53% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Peptidream in the last 3 months. The average price target is ¥3,230.00 with a high forecast of ¥4,400.00 and a low forecast of ¥2,700.00. The average price target represents a 93.53% change from the last price of ¥1,669.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1520":"¥1,520","4401":"¥4,401","2240.25":"¥2,240.3","2960.5":"¥2,960.5","3680.75":"¥3,680.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4400,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥4.40K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3230,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥3.23K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.70K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1520,2240.25,2960.5,3680.75,4401],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1531,1751.6923076923076,1972.3846153846152,2193.076923076923,2413.7692307692305,2634.461538461538,2855.153846153846,3075.846153846154,3296.5384615384614,3517.230769230769,3737.9230769230767,3958.6153846153843,4179.307692307692,{"y":4400,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1531,1661.6923076923076,1792.3846153846152,1923.076923076923,2053.7692307692305,2184.461538461538,2315.153846153846,2445.846153846154,2576.5384615384614,2707.230769230769,2837.9230769230767,2968.6153846153848,3099.3076923076924,{"y":3230,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1531,1620.923076923077,1710.8461538461538,1800.7692307692307,1890.6923076923076,1980.6153846153845,2070.5384615384614,2160.4615384615386,2250.3846153846152,2340.3076923076924,2430.230769230769,2520.153846153846,2610.076923076923,{"y":2700,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2625,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2625,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2700,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2146,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2145.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1984,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1622.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1671.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1530,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1521.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1559.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1731,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1531,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target¥4,400

Average Price Target¥3,230

Lowest Price Target¥2,700

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Akinori Ueda

Goldman Sachs

¥3,000→¥2,750

Buy

64.77%

Upside

Reiterated

02/17/26

Goldman Sachs Reaffirms Their Buy Rating on Peptidream (PPTDF)

Unknown Analyst

Nomura

Not Ranked

Nomura

¥2,700

Buy

61.77%

Upside

Reiterated

02/17/26

Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)

Unknown Analyst

SBI Securities

Not Ranked

SBI Securities

¥3,600

Buy

115.70%

Upside

Reiterated

12/24/25

Unknown Analyst

SMBC Nikko

Not Ranked

SMBC Nikko

¥2,700

Buy

61.77%

Upside

Reiterated

12/10/25

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

¥4,400

Buy

163.63%

Upside

Reiterated

12/09/25

Miyabi Yamakita

Jefferies

¥2,700→¥2,800

Buy

67.77%

Upside

Upgraded

02/27/25

Jefferies Upgrades PeptiDream Inc (4587:JP) to BuyJefferies analyst Stephen Barker upgraded PeptiDream Inc (4587:JP) from Hold to Buy with a price target of JPY2,800.00 (from JPY2,700.00).

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Akinori Ueda

Goldman Sachs

¥3,000→¥2,750

Buy

64.77%

Upside

Reiterated

02/17/26

Goldman Sachs Reaffirms Their Buy Rating on Peptidream (PPTDF)

Unknown Analyst

Nomura

Not Ranked

Nomura

¥2,700

Buy

61.77%

Upside

Reiterated

02/17/26

Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)

Unknown Analyst

SBI Securities

Not Ranked

SBI Securities

¥3,600

Buy

115.70%

Upside

Reiterated

12/24/25

Unknown Analyst

SMBC Nikko

Not Ranked

SMBC Nikko

¥2,700

Buy

61.77%

Upside

Reiterated

12/10/25

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

¥4,400

Buy

163.63%

Upside

Reiterated

12/09/25

Miyabi Yamakita

Jefferies

¥2,700→¥2,800

Buy

67.77%

Upside

Upgraded

02/27/25

Jefferies Upgrades PeptiDream Inc (4587:JP) to BuyJefferies analyst Stephen Barker upgraded PeptiDream Inc (4587:JP) from Hold to Buy with a price target of JPY2,800.00 (from JPY2,700.00).

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Peptidream

3 Months

xxx

Success Rate

0/1 ratings generated profit

Average Return

-1.20%

upgraded a xxx

rating 12 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -1.20% per trade.

1 Year

Akinori UedaGoldman Sachs

Success Rate

0/3 ratings generated profit

Average Return

-22.03%

reiterated a buy rating 7 days ago

Copying Akinori Ueda's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -22.03% per trade.

2 Years

xxx

Success Rate

0/3 ratings generated profit

Average Return

-23.93%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -23.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4587 Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 4587 has received 7 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. 4587 average Analyst price target in the past 3 months is 3,230.00.

Each month's total comprises the sum of three months' worth of ratings.

4587 Financial Forecast

4587 Earnings Forecast

Next quarter’s earnings estimate for 4587 is -¥4.64 with a range of -¥4.64 to -¥4.64. The previous quarter’s EPS was -¥4.11. 4587 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 4587 has Performed in-line its overall industry.

4587 Sales Forecast

Next quarter’s sales forecast for 4587 is ¥5.17B with a range of ¥5.17B to ¥5.17B. The previous quarter’s sales results were ¥5.66B. 4587 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 4587 has Performed in-line its overall industry.

4587 Stock Forecast FAQ

What is JP:4587’s average 12-month price target, according to analysts?

Based on analyst ratings, Peptidream Inc.’s 12-month average price target is 3,230.00.

What is JP:4587’s upside potential, based on the analysts’ average price target?

Peptidream Inc. has 93.53% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Peptidream Inc. a Buy, Sell or Hold?

Peptidream Inc. has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is Peptidream Inc.’s share price target?

The average share price target for Peptidream Inc. is 3,230.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ¥4,400.00 ,and the lowest forecast is ¥2,700.00. The average share price target represents 93.53% Increase from the current price of ¥1,669.

What do analysts say about Peptidream Inc.?

Peptidream Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of Peptidream Inc.?

To buy shares of JP:4587, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Peptidream (4587) Stock Forecast & Price Target

4587 Analyst Ratings

4587 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Peptidream

4587 Analyst Recommendation Trends

4587 Financial Forecast

4587 Earnings Forecast

4587 Sales Forecast

4587 Stock Forecast FAQ

Detailed List of Analyst Forecasts